Abstract
In many countries, carcinoma of the uterine cervix is the most common cancer in women. In advanced stages, treatment of this disease is complicated, expensive, and often unsuccessful. New data suggest strongly that venereal factors play a causative role in the development of this disease. Human papilloma virus (HPV) is the most important of these factors, and this finding may lead to a vaccine that could protect against cervical cancer. When medical resources are available, screening of asymptomatic women, with examination of exfoliated cells from the cervix (the Papanicolaou method, known as the “Pap” test), can result in detection of premalignant and early small cancers of the cervix that can be easily cured. Thus, increasingly, the emphasis in controlling this cancer has been on screening of asymptomatic women, and in the future it is likely to be on the prevention of critical venereal infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Further Reading
Uterine Cervical Cancer
Benedict JL, Anderson JH, Boyes A (1985) Colposcopic accuracy in the diagnosis of microinvasive and occult invasive carcinoma of the cervix. Obstetrics and Gynecology 65: 557–562
Guzick D (1978) Efficacy of screening for cervical cancer: a review. American Journal of Public Health 68: 125–134
Miller AB, Visentin T, Howe GR (1981) The effect of hysterectomies and screening on mortality from cancer of the uterus in Canada. International Journal of Cancer 27: 651–657
Munoz N, Bosch FX, Shah KV et al. (1992) The epidemiology of human papilloma virus and cervical cancer. IARC Scientific Publications No 119. International Agency for Research on Cancer, Lyon, pp 3–23
Richart R (1987) Causes and management of cervical intraepithelial neoplasia. Cancer 60: 1951–1956
Schiffman MH, Bauer HM, Hoover RN et al. (1993) Epidemiologic evidence showing that human papilloma virus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 85: 958–964
Shingleton HM, Orr JW Jr (1987) Cancer of the cervix: diagnosis and treatment. Churchill Livingstone, Edinburgh
Uterine Endometrium Cancer
Berman ML, Ballan SC, Logasse LD, Watring WG (1980) Prognosis and treatment of endometrial cancer. American Journal of Obstetrics and Gynecology 136: 679–688
Gusberg SB (1980) Current concepts in cancer: the changing nature of endometrial cancer. New England Journal of Medicine 302: 729–731
Malkasian GD Jr (1978) Carcinoma of the endometrium: effect of stage and grade on survival. Cancer 41: 996–1001
Uterine Endometrium Cancer
Backen M (1987) Incidence and aetiology of hydatidiform mole–an epidemiologic review. British Journal of Obstetrics and Gynaecology 94: 1123–1132
Berkowitz RS, Cramer DW, Bernstein MR et al. (1985) Risk factors for complete molar pregnancy from a case-study. American Journal of Obstetrics and Gynecology 152: 1016–1022
DuBeshler B, Berkowitz RS, Goldstein DP et al. (1987) Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center 1965–1985. Obstetrics and Gynecology 69: 390–402
Goldstein DP (1976) Chorionic gonadotropin. Cancer 38: 453–57
Goldstein DP, Berkowitz RS (1984) Staging system for gestational trophoblastic tumors. Journal of Reproductive Medicine 29: 792–798
Lurain JR, Brewer JI, Torok EE et al. (1982) Gestational trophoblastic disease: treatment results. Obstetrics and Gynecology 60: 354–359
Parazzini F, LaVecchia C, Mangili G et al. (1988) Dietary factors and risk of trophoblastic disease. American Journal of Obstetrics and Gynecology 158: 93–96
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ulmer, H.U., Hossfeld, D.K., Love, R.R. (1994). Cancers of the Uterine Cervix and Endometrium and Gestational Trophoblastic Disease. In: Love, R.R. (eds) Manual of Clinical Oncology. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85159-9_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-85159-9_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58193-2
Online ISBN: 978-3-642-85159-9
eBook Packages: Springer Book Archive